Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

Mutant BRCA1 genes antagonize phenotype of wild-type BRCA1

Abstract

Unregulated expression of wild-type BRCA1 (wtBRCA1) confers an altered phenotype in cultured human prostate cancer cells, characterized by chemosensitivity, susceptibility to apoptosis, decreased DNA repair activity, and alterations of key cell regulatory proteins. We now report that the expression of truncated or mutant full-length BRCA1 genes can abrogate certain phenotypic characteristics and/or confer the opposite phenotype to the wild-type BRCA1 gene. In particular, several carboxyl-terminal truncated BRCA1 proteins conferred chemoresistance, decreased susceptibility to apoptosis, and decreased ability to suppress in vivo tumor growth. These truncated BRCA1 proteins also blocked the ability of ectopically expressed wtBRCA1 to induce chemosensitivity and to inhibit estrogen receptor transcriptional activity. Studies using epitope-tagged truncated proteins confirmed their expression, nuclear localization, and functionality. On the other hand, in cells with no endogenous wild-type BRCA1 (HCC1937 human breast cancer cells), the wtBRCA1 gene enhanced cellular DNA repair activity and rendered the cells resistant to DNA damage; while truncated BRCA1 proteins blocked the wtBRCA1-induced chemoresistance. Our findings suggest that truncated BRCA1 proteins can inhibit the function of wild-type BRCA1. They raise the possibility that some inherited BRCA1 mutations may actively promote oncogenesis by blocking the function of the remaining wild-type BRCA1 allele, although this hypothesis remains to be proved.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7
Figure 8
Figure 9
Figure 10
Figure 11

Similar content being viewed by others

References

  • Abbott DW, Thompson ME, Robinson-Benion C, Tomlinson G, Jensen RA, Holt JT . 1999 J. Biol. Chem. 274: 18808–18812

  • Alley MC, Scudieco DA, Monks A, Hursey ML, Czerwinski MJ, Fine DL, Abbott BJ, Mayo JG, Shoemaker RH, Boyd MR . 1988 Cancer Res. 48: 589–601

  • Andres JL, Fan S, Turkel GJ, Wang J-A, Twu N-F, Yuan R-Q, Lamszus K, Golberg ID, Rosen EM . 1998 Oncogene 16: 2229–2241

  • Aprelikova ON, Fang BS, Meissner EG, Cotter S, Campbell M, Kuthiala A, Besho M, Jensen RA, Liu ET . 1999 Proc. Natl. Acad Sci. USA 96: 11866–11871

  • Bertrand R, Pommier Y . 1995 In: Studzinski GP (ed). Cell Growth and Apoptosis Oxford University Press pp. 97–117

  • Bochar DA, Wang L, Beniya H, Kinev A, Xue Y, Lane WS, Wang W, Kashanchi F, Shiekhatter R . 2000 Cell 102: 257–265

  • Chen CF, Li S, Chen Y, Chen PL, Sharp ZD, Lee WH . 1996a J. Biol. Chem. 271: 32863–32868

  • Chen Y, Farmer AA, Chen C-F, Jones DC, Chen P-L, Lee W-H . 1996b Cancer Res. 56: 3168–3172

  • Cortez D, Wang Y, Qin J, Elledge SJ . 1999 Science 286: 1162–1166

  • Dittmer D, Pati S, Zambetti G, Chu S, Teresky AK, Moore M, Finlay C, Levine AJ . 1993 Nat. Genet. 4: 42–46

  • Fan S, Wang J-A, Yuan R-Q, Ma YX, Meng Q, Goldberg ID, Rosen EM . 1998 Oncogene 16: 3069–3083

  • Fan S, Wang J-A, Meng Q, Yuan R-Q, Ma YX, Erdos MR, Pestell RG, Yuan F, Auborn KJ, Goldberg ID, Rosen EM . 1999a Science 284: 1354–1356

  • Fan S, Wang J-A, Yuan R-Q, Goldberg ID, Rosen EM . 1999b Prostate 40: 37–49

  • Fan S, Wang J-A, Ma YX, Wang C, Yuan R-Q, Meng Q, Erdos MR, Goldberg ID, Webb P, Kushner PJ, Pestell RG, Rosen EM . 2001a Oncogene 20: 77–87

  • Fan S, Yuan R-Q, Ma YX, Xiong J, Meng Q, Erdos M, Goldberg ID, Rosen EM . 2001b Oncogene 20: 4827–4841

  • Ford D, Easton DF, Bishop DT, Narod SA, Goldgar DE . 1994 Lancet 343: 692–695

  • Freundlieb S, Baron U, Bonin AL, Gossen M, Bujard H . 1997 Methods Enzymol. 283: 159–173

  • Friedman LS, Ostermeyer EA, Szabo CI, Dowd P, Lynch ED, Rowell SE, King MC . 1994 Nat. Genet. 8: 399–404

  • Gao B, Shen X, Kunos G, Meng Q, Goldberg ID, Rosen EM, Fan S . 2001 FEBS Lett. 488: 179–184

  • Gayther SA, Warren W, Mazoyer S, Russell PA, Harrington PA, Chiano M, Seal S, Hamoudi R, Rensburg EJ, Dunning, Love R, Evans G, Easton D, Clayton D, Stratton MR, Ponder BAJ . 1995 Nat. Genet. 11: 428–433

  • Gowen LC, Avrutskaya AV, Latour AM, Koller BH, Leadon SA . 1998 Science 281: 1009–1012

  • Hakem R, de la Pomba JL, Sirard C, Mo R, Woo M, Hakem A, Wakeham A, Potter J, Reitmair A, Billia F, Firpo E, Hui CC, Roberts J, Rossant J, Mak TW . 1996 Cell 85: 1009–1023

  • Harkin DP, Bean JM, Miklos D, Song YH, Truong VB, Englert C, Christians FC, Ellisen LW, Mahenwaran S, Oliner JD, Haber DA . 1999 Cell 97: 575–586

  • Henttu PMA, Kalkhoven E, Parker MG . 1998 Mol. Cell. Biol. 17: 1832–1939

  • Herrmann M, Lorenz H-M, Voll R, Grunke M, Woith W, Kalden JR . 1994 Nucl. Acids Res. 22: 5506–5507

  • Holt JT, Thompson ME, Szabo C, Robinson-Benion C, Arteaga CL, King M-C, Jensen RA . 1996 Nat. Genet. 12: 298–302

  • Lukas J, Jadayel D, Bartkova J, Nacheva E, Dyer MJ, Strauss M, Bartek J . 1994 Oncogene 9: 2159–2167

  • Miki Y, Swensen J, Shattuck-Eidens D, Futreal PA, Harshman K, Tavtigian S, Liu Q, Cochran C, Bennett LM, Ding W, Bell R, Rosenthal J, Hussey C, Tran T, McClure M, Frye C, Hattier T, Phelps R, Haugen-Strano A, Katcher H, Yakumo K, Gholami Z, Shaffer D, Stone S, Bayer S, Wray C, Bogden R, Dayanath P, Ward J, Tonin P, Narod S, Bristow P, Norris FH, Helvering L, Morrison P, Rosteck P, Lai M, Barrett JC, Lewis C, Neuhausen S, Cannon-Albright L, Goldgar D, Wiseman R, Kamb A, Skolnick MH . 1994 Science 266: 66–71

  • Monteiro AN, August A, Hanafusa H . 1996 Proc. Natl. Acad. Sci. USA 93: 13595–13599

  • Moynahan ME, Chiu JW, Koller BH, Jasin M . 1999 Mol. Cell 4: 511–518

  • Ouichi T, Monteiro AN, August A, Aarsonson SA, Hanafusa H . 1998 Proc. Natl. Acad. Sci. USA 95: 2302–2306

  • Rajan JV, Wang M, Marquis ST, Chodosh LA . 1997 Proc. Natl. Acad. Sci. USA 93: 3078–3083

  • Rao VN, Shao N, Ahmad M, Reddy ES . 1996 Oncogene 12: 523–528

  • Runnebaum IB, Nagarajan M, Bowman M, Soto D, Sukumar S . 1991 Proc. Natl. Acad. Sci. USA 88: 10657–10661

  • Sarkar FH, Sakr W, Li YW, Macoska J, Ball DE, Crissman JD . 1992 Prostate 21: 145–152

  • Scully R, Anderson SF, Chao DM, Wei W, Ye L, Young RA, Livingston DM, Parvin JD . 1997a Proc. Natl. Acad. Sci. USA 94: 5605–5610

  • Scully R, Chen J, Plug A, Xiao P, Weaver D, Feunteau J, Ashley T, Livingston D . 1997b Cell 88: 265–275

  • Scully R, Chen J, Ochs RL, Keegan K, Hoekstra M, Feunteun J, Livingston D . 1997c Cell 90: 425–435

  • Shao N, Chai YL, Shyam E, Reddy P, Rao VM . 1996 Oncogene 13: 1–7

  • Shaulian E, Zauberman A, Ginsberg D, Oren M . 1992 Mol. Cell Biol. 12: 5581–5592

  • Somasundaram K, Zhang H, Zeng Y-X, Houvras Y, Peng Y, Zhang H, Wu GS, Licht JD, Weber BL, El-Deiry WS . 1997 Nature 389: 187–190

  • Streuwing JP, Hartge P, Wacholder S, Baker SM, Berlin M. McAdams M, Timmerman MM, Brody LC, Tucker MA . 1997 New Engl, J, Med. 336: 1401–1408

  • Taylor J, Lamboura M, Pace PE, A′hern RP, Desai AJ, Shousha S, Coombes RC, Ali S . 1998 Int. J. Cancer 79: 334–342

  • Thompson ME, Jensen RA, Obermiller PS, Page DL, Holt JT . 1995 Nat. Genet. 9: 444–450

  • Tirkkonen M, Johannson O, Agnarsson BA, Olsson H, Ingvarsson S, Karbu R, Tanner M, Isola J, Barkardottir RB, Borg A, Kallioniemi OP . 1997 Cancer Res. 57: 1222–1227

  • Vaughn JP, Davis PL, Jarboe MD, Huper G, Evans AC, Weisman RW, Berchuck A, Inglehart JD, Futreal PA, Marks JR . 1996 Cell Growth Differ. 7: 711–715

  • Wang H, Shao N, Ding OM, Qui J-Q, Reddy ESP, Rao VN . 1997 Oncogene 15: 143–157

  • Wang P, Zhang H, Kajino K, Greene MI . 1999 Oncogene 17: 1939–1948

  • Watts CK, Brady A, Sarcevic B, deFazio A, Musgrove EA, Sutherland RL . 1995 Mol. Endocrinol. 9: 1804–1813

  • Wu LC, Wang ZW, Tsan JT, Spillman MA, Phung A, Zu XL, Yang MC, Hwang LW, Bowcock AM, Baer R . 1996 Nat. Genet. 14: 430–440

  • Yarden RI, Brody LC . 1999 Proc. Natl. Acad. Sci. USA 96: 4983–4988

  • Yu X, Wu LC, Bowcock AM, Aronheim A, Baer R . 1998 J. Biol. Chem. 273: 25388–25392

  • Zhang H, Somasundaram K, Peng Y, Tian H, Zhang H, Bi D, Weber BL, El-Deiry WS . 1998 Oncogene 16: 1713–1721

Download references

Acknowledgements

This research was supported, in part, by research grants from the USPHS (R01-ES09169, R01-CA-80000, and R01-CA82599), the Susan G Komen Breast Cancer Foundation (BASIC-003255), and the US Army Breast Cancer Research Program (DAMD17-99-1-9254).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Eliot M Rosen.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Fan, S., Yuan, Rq., Ma, Y. et al. Mutant BRCA1 genes antagonize phenotype of wild-type BRCA1. Oncogene 20, 8215–8235 (2001). https://doi.org/10.1038/sj.onc.1205033

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1205033

Keywords

This article is cited by

Search

Quick links